| Dr Daniel S Fuglestad, MD | |
|
101 Willmar Ave Sw, Willmar, MN 56201 | |
| (320) 231-5000 | |
| (320) 231-5067 |
| Full Name | Dr Daniel S Fuglestad |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 101 Willmar Ave Sw, Willmar, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215903935 | NPI | - | NPPES |
| 676085600 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35196 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda Home Health | Willmar, MN | Home health agency |
| Carris Health Llc | Willmar, MN | Hospital |
| Bethesda | Willmar, MN | Nursing home |
| Clara City Care Center | Clara city, MN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centracare Clinic Southwest Llc | 8426457946 | 141 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.
A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.
While many academic institutions are searching for ways to prevent sexual assault and sexual coercion among their faculty members, staff and students, they are failing to address the most common forms of gender-based harassment, say experts who study harassment and discrimination at work and in academic and health care settings.
› Verified 4 days ago
| Entity Name | Carris Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598236408 PECOS PAC ID: 7012274228 Enrollment ID: O20190503001162 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.
A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.
While many academic institutions are searching for ways to prevent sexual assault and sexual coercion among their faculty members, staff and students, they are failing to address the most common forms of gender-based harassment, say experts who study harassment and discrimination at work and in academic and health care settings.
› Verified 4 days ago
| Entity Name | Centracare Clinic Southwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174106264 PECOS PAC ID: 8426457946 Enrollment ID: O20210602002802 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.
A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.
While many academic institutions are searching for ways to prevent sexual assault and sexual coercion among their faculty members, staff and students, they are failing to address the most common forms of gender-based harassment, say experts who study harassment and discrimination at work and in academic and health care settings.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel S Fuglestad, MD 101 Willmar Ave Sw, Willmar, MN 56201 Ph: (320) 231-5000 | Dr Daniel S Fuglestad, MD 101 Willmar Ave Sw, Willmar, MN 56201 Ph: (320) 231-5000 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.
Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.
A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.
While many academic institutions are searching for ways to prevent sexual assault and sexual coercion among their faculty members, staff and students, they are failing to address the most common forms of gender-based harassment, say experts who study harassment and discrimination at work and in academic and health care settings.
› Verified 4 days ago
Lee M Haggenjos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw Ste 1, Willmar, MN 56201 Phone: 320-235-7232 | |
Dr. Raymond J Mellema, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Dr. Robert M Kaiser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Maria Jones Loerzel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8602 | |
Shelly M Staska, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5026 | |
Rachel L Tollefsrud, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8609 | |
Dr. William E. Hicks, M. D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Avenue Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 |